Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

Minimally invasive lymph node dissection in breast cancer has advantages over conventional surgery

09.11.2012
Promising results reported in Mayo Clinic Proceedings

Axillary lymph node dissection is done in conjunction with lumpectomy or mastectomy to determine if breast cancer has spread to the adjoining lymph nodes. The conventional surgical approach leaves a surgical scar that is unattractive and can restrict range of motion in the shoulder joint.

Also, squeezing and pulling the tumor during the breast operation can stimulate tumor cell metastases. A new study in the December issue of Mayo Clinic Proceedings reports that an endoscopic technique, mastoscopic axillary lymph node dissection (MALND), can reduce these complications.

"Patients who undergo MALND experience improved operative outcomes, fewer complications, better functional conservation, and more attractive cosmetic results," says lead investigator Chengyu Luo, MD, of Fuxing Hospital, Capital Medical University, Beijing, China. "When performed by a well-trained surgeon, it is the treatment of choice."

1027 patients with operable breast cancer were randomly assigned to one of two study groups. The first group underwent a breast operation and axillary lymph node dissection by conventional surgical means (CALND). The second group first underwent MALND and then conventional breast surgery. Both groups were treated post-operatively with systemic therapy and radiation therapy. The patients were followed for 63 months.

The average blood loss in the MALND group was lower than that in the CALND group. There was no significant difference between the two groups with respect to operative time. The patients who underwent MALND had less axillary pain, numbness, paresthesias and arm swelling. The aesthetic appearance of the axilla was much better in the MALND group than in the CALND group.

No statistically significant difference in disease free survival or overall survival between the two groups was observed. However, there was a significant difference between the two groups in the distant metastasis rate in favor of the MALND group. "This is the most significant finding of the study," says Dr. Luo.

"While there is not as yet any significant difference in survival, longer term follow-up (e.g., 10 years and 20 years) is still needed to make a definitive conclusion. This may suggest that the axillary operation should be done before the breast operation even in conventional surgery."

Rachael Zaleski | EurekAlert!
Further information:
http://www.elsevier.com

More articles from Health and Medicine:

nachricht New substance overcomes treatment-resistance in leukaemia
28.11.2014 | Goethe-Universität Frankfurt am Main

nachricht Stroke damage mechanism identified
28.11.2014 | University of Leeds

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Anzeige

Anzeige

IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics
Veranstaltungen

Innovationspotenzial der Metallindustrie wecken: Innovationstag Lasertechnik am LZH

28.11.2014 | Veranstaltungen

4. Bonner Dialog für Cybersicherheit zum Thema Industrie 4.0 – mit Sicherheit sicher?

28.11.2014 | Veranstaltungen

2. Tagung Schwimmende Bauten

27.11.2014 | Veranstaltungen

 
B2B-VideoLinks
Weitere VideoLinks >>>
Aktuelle Beiträge

Erste Hilfe für gestresste Proteine

28.11.2014 | Biowissenschaften Chemie

Der neue Siemens-Campus in Zug nimmt Form an

28.11.2014 | Unternehmensmeldung

Hochauflösende Ionensonde für aktuelle Forschungsfragen in der Kosmochemie

28.11.2014 | Geowissenschaften